Therefore, the inhibition of CYP2B6 by xenobiotics or dietary fats can exacerbate obesity and metabolic disease potentially through disrupted PUFA metabolism and the production of key lipid metabolites. The gene discussed is CYP2B6; the disease is obesity due to melanocortin 4 receptor deficiency.